Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): An immunogenic, cost-effective and practical regimen

Vaccine

Volumn 24, Issue 19, 2006, Pages 4116-4121

  Ambrozaitis, Arvydas ^a   Laiškonis, Alvydas ^b   Balčiuniene, Ligita ^a   Banzhoff, Angelika ^c   Malerczyk, Claudius ^c  

^a VILNIUS UNIVERSITY   (Lithuania)

^b KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^c Clinical Research and Medical Affairs   (Germany)

Author keywords

Four site regimen; Intradermal; PCECV; Post exposure prophylaxis; PVRV; Rabies; Vaccination

Indexed keywords

NEUTRALIZING ANTIBODY; RABIES IMMUNOGLOBULIN; RABIES VACCINE;

ADULT; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTHRALGIA; ARTICLE; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; FLUORESCENCE ANALYSIS; HEALTH ECONOMICS; HUMAN; IMMUNOGENICITY; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE SWELLING; MALAISE; MALE; MULTICENTER STUDY; MYALGIA; NAUSEA; NORMAL HUMAN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROPHYLAXIS; RABIES; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; VACCINATION; VACCINATION REACTION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; CHICK EMBRYO; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INJECTIONS, INTRADERMAL; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; RABIES; RABIES VACCINES; RABIES VIRUS; SAFETY; SINGLE-BLIND METHOD; VERO CELLS;

EID: 33646493491     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.02.036     Document Type: Article

References (20)

1. Jackson A.C., Warrell M.J., Rupprecht C.E., et al. Management of rabies in humans. Clin Infect Dis 36 1 (2003, Jan 1) 60-63
2. Fu Z.F., and Jackson A.C. Neuronal dysfunction and death in rabies virus infection. J Neurovirol 11 1 (2005) 101-106
3. Willoughby Jr. R.E., Tieves K.S., Hoffman G.M., et al. Survival after treatment of rabies with induction of coma. New Engl J Med 352 24 (2005) 2508-2514
4. Knobel D.L., Cleaveland S., Coleman P.G., et al. Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 83 5 (2005) 360-368
5. Briggs D.J., Banzhoff A., Nicolay U., et al. Antibody response of patients after post-exposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified vero cell rabies vaccine. Bull World Health Organ 78 5 (2000) 693-698
6. Quiambao B.P., Dimaano E.M., Ambas C., Davis R., Banzhoff A., and Malerczyk C. Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0 1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals. Vaccine 23 14 (2005) 1709-1714
7. Madhusudana S.N., Anand N.P., and Shamsundar R. Economical multi-site intradermal regimen with purified chick embryo cell vaccine (Rabipur) prevents rabies in people bitten by confirmed rabid animals. Int J Infect Dis 6 (2002) 210-214
8. Jaiiaroensup W., Lang J., Thipkong P., et al. Safety and efficacy of purified vero cell rabies vaccine given intramuscularly and intradermally (results of a prospective randomized trial). Vaccine 16 16 (1998) 1559-1562
9. Kamoltham T., Singhsa J., Promsaranee U., Sonthon P., Mathean P., and Thinyounyong W. Elimination of human rabies in a canine endemic province in Thailand: five-year programme. Bull World Health Organ 81 5 (2003) 375-381
10. Chutivongse S., Wilde H., Supich C., Baer G.M., and Fishbein D.B. Post-exposure prophylaxis for rabies with antiserum and intradermal vaccination. Lancet 335 8694 (1990) 896-898
11. Beran J., Honegr K., Banzhoff A., and Malerczyk C. Potency requirements of rabies vaccines administered intradermally using the Thai Red Cross regimen: investigation of the immunogenicity of serially diluted purified chick embryo cell rabies vaccine. Vaccine 23 30 (2005) 3902-3907
12. WHO. WHO expert consultation on rabies, first report. Geneva, Switzerland: WHO; October 5, 2004. Report No. 931.
13. Smith J.S., Yager P.A., and Baer G.M. A rapid tissue culture test for determining rabies neutralizing antibody. Monogr Ser World Health Organ 23 (1973) 354-357
14. Smith J.S., Yager P.A., and Baer G.M. A rapid tissue culture test for determining rabies-neutralizing antibody. In: Meslin F.X., Kaplan M.M., and Koprowski H. (Eds). Laboratory techniques in rabies (1996), WHO, Geneva, Switzerland 354-357
15. Moore S., Ricke T., Davis R.D., and Briggs D. The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays. Biologicals (2005)
16. OIE. Conclusions and Recommendations of the First International Conference "Rabies in Europe", Kiev, Ukraine, 15-18 June, 2006. Available at http://www.oie.int (assessed 04 January, 2006).
17. Fitzgerald E.A., and Rastogi S.C. A collaborative study to establish an International Standard Rabies immunoglobulin of human origin. J Biol Stand 13 4 (1985) 327-333
18. Cox J.H., and Schneider L.G. Prophylactic immunization of humans against rabies by intradermal inoculation of human diploid cell culture vaccine. J Clin Microbiol 3 2 (1976) 96-101
19. WHO. WHO expert committee on rabies, 8th report. 1992. Report No. 824.
20. WHO. WHO recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies. WHO; 1997. p. 1-26.